OpticStrive - Our Research Wing
Innovative R&D Solutions and Manufacturing
Our R&D strategy is led by a world-class in-house development team and supplemented by creative product development partnerships with external stakeholders. The focus of our FR&D strategies is ensuring the ongoing innovation of important and value-generating products across our portfolios.
Shaimil FR&D wing offers comprehensive solutions for preformulation, formulation development of conventional and novel drug dosage forms, analytical method development and validation, stability and scale up.
We also provide services for bioavailability, bioequivalence, bioanalysis, pharmacokinetics, biostatistics and clinical diagnostics.
Add to the above, we offer solutions for commercial manufacturing by coordination of outsourced contract manufacturing services at locations where we enjoy a preferred customer status.
Contract Research and Manufacturing Services (CRAMS)
We have completely integrated R&D, technology and engineering capabilities that enable us to be cost effective partners on a sustainable basis. We have built strong alliances and continuing relationships with top global generic companies to offer R&D and formulation development services.
The Contract Manufacturing Division is being set up to address the challenges and opportunities created due to increasing R&D costs, low R&D productivity, impending patent expirations and at the same time, pressure to reduce healthcare costs. This in turn has propelled global pharma majors to cut costs and improve overall profitability. This is expected to translate into a strong outsourcing potential for low cost manufacturing destinations like India.
Contract Research and Development of Formulation In-house
This includes a technology development which could be in form of a non-infringing pathway or a novel formulation matrix with complete validations. It also involves confidential technology transfer of the process, exclusivity depending on initial terms and conditions with the customer
Contract Manufacturing of Products as per Tech Transfer by the customer
This includes in-house manufacturing of the product adhering to the transferred technology by the customer, under highly restrictive confidentiality agreement.
Kilo & Pilot Scale Manufacturing (non-GMP & GMP) TOX and Clinical Quantities
Contract Research and Manufacturing In-House
Complying with the requirements of the customer, we design the formulation, analytical data, Impurity Profiling (including impurity & reference standard synthesis), Process Validation followed by Commercial Manufacturing, ICH Stability Studies and further upscale it to the manufacturing scale
Contract Research and Development of Formulation In-house
This includes a technology development which could be in form of a non-infringing pathway or a novel formulation matrix with complete validations. It also involves confidential technology transfer of the process, exclusivity depending on initial terms and conditions with the customer
Contract Manufacturing of Products as per Tech Transfer by the customer
This includes in-house manufacturing of the product adhering to the transferred technology by the customer, under highly restrictive confidentiality agreement.
Kilo & Pilot Scale Manufacturing (non-GMP & GMP) TOX and Clinical Quantities
Contract Research and Manufacturing In-House
Complying with the requirements of the customer, we design the formulation, analytical data, Impurity Profiling (including impurity & reference standard synthesis), Process Validation followed by Commercial Manufacturing, ICH Stability Studies and further upscale it to the manufacturing scale
Out licencing
- Global Collaboration: We are committed to developing new drug products and has embarked on forging out-licensing agreements with other global pharmaceutical.
- Strategic Partnerships: Finding partners that can aid in identifying the target market and getting the product into the proper hands is the process of Medicine Out Licensing India. Working with marketing companies or legal firms may be a part of this process.
